Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID). [electronic resource]
Producer: 20130702Description: 2153-6 p. digitalISSN:- 1499-2752
- Adult
- Aged
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis -- drug therapy
- Antibodies, Monoclonal, Murine-Derived -- adverse effects
- Antirheumatic Agents -- adverse effects
- Cohort Studies
- Dose-Response Relationship, Drug
- Female
- Germany -- epidemiology
- Humans
- Male
- Middle Aged
- Registries
- Retrospective Studies
- Rituximab
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.